In this issue:
- Fifteen-year prostate cancer outcomes after monitoring, surgery, or radiotherapy
- Cabozantinib + nivolumab and ipilimumab in RCC
- Radiation-based therapy for MIBC
- Metastatic bladder cancer expression and localisation of nectin-4 and trop-2
- Very long-term remission with high-risk localised prostate cancer
- Late relapse of germ cell tumours after prior chemotherapy
- Inflammation biomarkers in penile SCC
- Abiraterone + enzalutamide for metastatic prostate cancer
- Belzutifan + cabozantinib for advanced clear cell RCC
- Transcriptomic and clinical heterogeneity of metastatic disease timing in mCSPC
Please login below to download this issue (PDF)